HOME >> MEDICINE >> NEWS
Ethical committee members have different views on how to evaluate clinical trials

Members of ethical committees, which decide whether or not to grant approval for phase two clinical trials, infrequently use systematic methods when weighing up the risks and benefits of a study, according to research published today (Thursday 1 August) in the Annals of Oncology, the journal of the European Society for Medical Oncology.*

A team of researchers from The Netherlands report that members of Institutional Review Boards (or ethical committees) use a variety of ways to identify, estimate and evaluate the risks and benefits associated with phase two clinical cancer trials, and their approach often depends on their own professional background.

However, Professor Neil Aaronson, Head of the Division of Psychosocial Research and Epidemiology at The Netherlands Cancer Institute in Amsterdam and senior author of the paper, says this is not necessarily a problem because the ethical committees reach collective decisions on whether or not to grant approval to clinical trials, and the different experiences of the individual members may actually strengthen the decision-making process. "Undoubtedly the whole is more than the sum of its parts," he said.

The study, carried out by Dr Heleen van Luijn of the Institute for Ethics at the Vrije University in Amsterdam, involved interviews with 53 members of Institutional Review Boards (IRBs) from six research hospitals and specialist cancer centres in The Netherlands. The IRB members were asked about their attitudes, beliefs and experiences in evaluating the risk/benefit ratios of phase two clinical trials. In particular, they focused on: how members identified the risks and benefits of trials; how much information they needed to make a risk/benefit assessment and whether such information is usually available in phase two clinical trial protocols; how they perceive their own competence in making risk/benefit assessments; and how they evaluate specific risks and benefits of the trials to participating
'"/>

Contact: Emma Mason
wordmason@aol.com
44-1376-563090
European Society for Medical Oncology
31-Jul-2002


Page: 1 2 3 4

Related medicine news :

1. Ethical discussion should come before research
2. Teaching a less obvious medical skill -- Ethical decision-making
3. Ethical review of research in developing countries needed
4. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
5. Duke Physicians: Clinicians Have Ethical Obligation To Consider Alternative Medicine
6. National vaccine advisory committee issues recommendations to strengthen supply of routine vaccines
7. Emorys Jeffrey Koplan joins Hong Kong SARS expert committee in report to government
8. Dentists deliver preventive messages to finance committee
9. FDA advisory committee recommends approval of novantrone for treatment of worsening multiple sclerosis
10. eDocAmerica launches Hispanic Website for members
11. Parent, guardian job loss may boost smoking among adolescent family members

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/7/2020)... (PRWEB) , ... April 07, 2020 , ... ... overcrowding due to the pandemic, FieldMed, a dedicated community health software platform, announced ... practitioners to connect patients directly with doctors without ever leaving their homes. In ...
(Date:4/5/2020)... ... April 04, 2020 , ... Visiun, the leader ... mandated federal reporting of COVID-19 testing that must be submitted to HHS and ... Pence announced that all hospitals report data on COVID-19 testing performed by “in-house” ...
(Date:4/2/2020)... Ontario (PRWEB) , ... April 02, 2020 , ... ... VetFolio , today announced the launch of the veterinary CE course COVID-19: ... free indefinitely for VetFolio subscribers. , “When it comes to COVID-19, it’s important for ...
(Date:4/1/2020)... ... April 02, 2020 , ... AAGL Gynecologic ... pm ET- to discuss surgical safety practices in response to the COVID-19 crisis. ... University Healthcare Network in New Orleans and Amsterdam University Medical Center in the ...
(Date:4/1/2020)... ... April 01, 2020 , ... Velocidy Bio ’s Dutch biotech ... NEXTGENPCR that decreases the testing time for SARS-CoV-2 to eight minutes, compared to ... size of a shoebox could perform a hundred and eighty (180) amplification runs a ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... ... April 02, 2020 , ... On ... will be initiating the 2nd annual Medical Hero Appreci-a-thon to bring the global ... medical and healthcare professionals, researchers and study volunteers. CISCRP invites the public ...
(Date:4/1/2020)... ... April 01, 2020 , ... In response to calls for ... manufacturers nation-wide scramble to retool their machinery to build N95 masks and ventilators, ... using hand-sewn masks to protect employees from contracting infectious diseases. “We don’t know ...
(Date:3/30/2020)... BOSTON (PRWEB) , ... March 30, 2020 , ... ... e-signature has become critical for business continuity. Unfortunately, we hear stories from our ... do that. It’s unconscionable to take advantage of people’s hardships in this difficult ...
Breaking Medicine Technology:
Cached News: